Cargando…
A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer
Methionine synthase (METH, i.e., MTR) is a key enzyme in the folate pathway, which plays a critical role in the synthesis, repair, and methylation of DNA. The association between METH gene polymorphisms and prostate cancer susceptibility remains ambiguous. Thus, we performed an updated meta-analysis...
Autores principales: | Zhang, Xiaosong, Tang, Jilei, Shen, Nan, Ren, Kewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224252/ https://www.ncbi.nlm.nih.gov/pubmed/30337500 http://dx.doi.org/10.18632/aging.101584 |
Ejemplares similares
-
Association of methionine synthase rs1801394 and methionine synthase reductase rs1805087 polymorphisms with meningioma in adults: A meta-analysis
por: ZENG, XIAN-TAO, et al.
Publicado: (2014) -
Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer
por: Zhang, Wei, et al.
Publicado: (2020) -
Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer
por: Chen, Hao, et al.
Publicado: (2017) -
Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer
por: Shao, Hong-Bao, et al.
Publicado: (2018) -
Association between interleukin-21 gene rs6822844 polymorphism and rheumatoid arthritis susceptibility
por: Ren, Kewei, et al.
Publicado: (2019)